Hangzhou Coco Healthcare Products Co.Ltd. (301009) — Cash Flow Reinvestment Rate

Latest as of June 2025: 3.46x

Hangzhou Coco Healthcare Products Co.Ltd. (301009) has a Cash Flow Reinvestment Rate of 3.46x as of June 2025, reinvesting CN¥42.27 Million (capex CN¥4.26 Million plus investments CN¥-38.01 Million) from operating cash flow of CN¥12.21 Million. Explore how much does Hangzhou Coco Healthcare Products Co.Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

3.46x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥42.27 Million
Capex + Investments

Operating Cash Flow

CN¥12.21 Million
CNY

Capital Expenditures

CN¥4.26 Million
CNY

Hangzhou Coco Healthcare Products Co.Ltd. Cash Flow Reinvestment Rate (2017–2024)

Historical reinvestment intensity for Hangzhou Coco Healthcare Products Co.Ltd. across 7 annual periods. Also explore 301009 total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Hangzhou Coco Healthcare Products Co.Ltd. (2017–2024)

Year-by-year capital reinvestment analysis for Hangzhou Coco Healthcare Products Co.Ltd.. For live market cap and broader valuation context, see 301009 market cap overview.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2024 6.35x CN¥332.91 Million CN¥52.44 Million CN¥75.35 Million ▲ +938.0%
2023 0.61x CN¥139.26 Million CN¥227.70 Million CN¥66.01 Million ▼ -91.3%
2021 7.03x CN¥355.37 Million CN¥50.53 Million CN¥240.45 Million ▲ +423.2%
2020 1.34x CN¥532.18 Million CN¥395.86 Million CN¥220.71 Million ▲ +14.8%
2019 1.17x CN¥261.58 Million CN¥223.33 Million CN¥125.86 Million ▲ +49.1%
2018 0.79x CN¥89.78 Million CN¥114.26 Million CN¥89.78 Million ▲ +11.4%
2017 0.71x CN¥77.41 Million CN¥109.74 Million CN¥77.41 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow